-
- Company
Groundbreaking stem cell therapy ACP-01 sets new standards in regenerative medicine
Biotech company Hemostemix: A potential winner of the longevity trend?
The stock of the Canadian biotech company Hemostemix Inc. (TSXV:HEM, FSE:2VF0) has been tradable on the regulated US OTCQB exchange under the symbol HMTXF since January 23, 2025. Until then, Hemostemix only had a simple OTC listing. The company expects the new listing to improve tradability and incr…








